FDA NDC Directory · JSON-LD · Markdown

Galantamine Hydrobromide

NDC 47335-835 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerSun Pharmaceutical Industries, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090178
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsGALANTAMINE HYDROBROMIDE (8 mg/1)
Marketing started20110209
Package count4

External sources

Source: openFDA. Public-domain (CC0).